|
NFYC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.93882753874686E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46000000977864E-09 |
| Normal-vs-Stage2 |
1.792380E-01 |
| Normal-vs-Stage3 |
1.8043344596208E-12 |
| Normal-vs-Stage4 |
1.62714286489063E-12 |
| Stage1-vs-Stage2 |
6.164600E-03 |
| Stage1-vs-Stage3 |
4.104200E-03 |
| Stage1-vs-Stage4 |
5.59279999999829E-05 |
| Stage2-vs-Stage3 |
2.32999999999484E-05 |
| Stage2-vs-Stage4 |
4.92770000004583E-06 |
| Stage3-vs-Stage4 |
2.896600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.87307980026708E-13 |
| Normal-vs-AfricanAmerican |
4.856800E-03 |
| Normal-vs-Asian |
3.2139000016862E-08 |
| Caucasian-vs-AfricanAmerican |
3.365000E-01 |
| Caucasian-vs-Asian |
1.811970E-01 |
| AfricanAmerican-vs-Asian |
7.700200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.50669999494136E-08 |
| Normal-vs-Female |
6.76547706746078E-12 |
| Male-vs-Female |
4.710600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.72380004609596E-09 |
| Normal-vs-Age(41-60Yrs) |
1.18610010702014E-10 |
| Normal-vs-Age(61-80Yrs) |
1.02400000034919E-07 |
| Normal-vs-Age(81-100Yrs) |
7.91379999975916E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.487400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.283800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.253440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.879000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.846810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.062200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.22079999945279E-07 |
| Classical-VS-Follicular |
3.72889999988857E-08 |
| Classical-VS-Other |
2.464600E-01 |
| Classical-VS-Normal |
2.08877359852977E-12 |
| Tall-VS-Follicular |
1.6286971771251E-12 |
| Tall-VS-Other |
8.898100E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.808000E-01 |
| Follicular-VS-Normal |
4.236000E-01 |
| Other-VS-Normal |
3.037000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67990000033269E-07 |
| Normal-vs-N1 |
3.2085445411667E-14 |
| N0-vs-N1 |
2.36049999999821E-05 |
|
|
